Key takeaways
- HSA distinguishes a tablet line for easier swallowing from a line that divides equal amounts. The leaflet must explain its purpose. HSA Appendix 7
- Check the form and route on the carton. Strength may be per tablet, measured volume, actuation, gram or a patch’s labelled time; those expressions describe different delivery systems. HSA
- Ask before crushing, opening, dissolving, splitting or substituting. If swallowing food or drink is difficult too, the NHS says to seek advice instead of practising its pill techniques, because you might choke. NHS
Tablets, Capsules, Liquids, Patches and Inhalers: Why Dosage Form Matters
A dosage form is the physical form in which a medicine is supplied, such as a tablet, liquid, cream, patch or inhaler. It is part of how the medicine reaches its intended site and how its strength is expressed. Two products can share an active ingredient yet require different technique, timing or safety checks because their forms or routes are different.
What is the difference between dosage form and route?
Dosage form describes the finished product; route describes where or how it is used.
| Dosage form | Common route | Label detail that matters |
|---|---|---|
| Tablet or capsule | Oral | Strength per unit; standard or modified release; coating and split/open instructions |
| Oral solution or suspension | Oral | Concentration per measured volume; whether shaking or a measuring device is required |
| Cream, ointment or gel | Topical | Strength per gram or percentage; application site and whether skin must be intact |
| Patch | Transdermal or topical | Delivery or content statement, wear time and application instructions |
| Metered inhaler or dry-powder inhaler | Inhalation | Amount per actuation, device technique and dose counter |
| Eye or ear drops | Ophthalmic or otic | Correct body site, concentration, sterility and in-use period |
| Suppository | Rectal or vaginal, depending on product | Strength per unit and intended route |
The pair matters. “Solution” alone does not say whether a product is swallowed, inhaled, injected or used in an eye. A medicine name without route and form is therefore incomplete.
Regulators treat these as core product characteristics. The FDA requires a conventional generic to use the same dosage form and route as its reference medicine. Singapore HSA product records likewise display dosage form and route separately.
Are tablets and capsules interchangeable?
Appearance and the ingredient name cannot establish whether a tablet can replace a capsule. A standard tablet and capsule may sometimes be authorised alternatives, subject to a product-specific regulatory and clinical check. Their shell, excipients, dissolution and instructions can differ. A capsule may contain powder, liquid or specially coated pellets; a tablet may be uncoated, film-coated, chewable, dispersible, enteric-coated or designed to release medicine over time.
This is why “it is still oral” is not enough. The FDA’s Orange Book definitions classify different dosage forms as pharmaceutical alternatives rather than pharmaceutical equivalents. A pharmacist needs the exact products and prescription to decide what can replace what under local rules.
A liquid may help with a large tablet that is hard to swallow, yet create measuring difficulties for someone with poor vision or hand control. Taste, storage, portability and a suitable device matter too. The NHS lists dry mouth, fear of choking and dysphagia, including after stroke, among causes of pill-swallowing difficulty. If food and drink are also difficult to swallow, seek advice rather than trying its pill techniques because of choking risk. NHS
What is different about oral liquids?
Liquid strength is a concentration, such as an amount in each 5 mL. The first number is not the volume to take; it is the amount of active ingredient in the stated volume. Two bottles can contain the same ingredient but different concentrations, so copying a volume from an old label can be dangerous.
Some liquids are solutions, in which the ingredient is dissolved. Others are suspensions, in which particles are dispersed and may settle; the label may instruct the user to shake before measuring. Some powders must be mixed to form a liquid. HSA Appendix 7 calls for a description of appearance before and after reconstitution and for applicable storage and in-use shelf-life instructions after mixing or opening. HSA
Use the supplied or recommended oral syringe, cup or spoon. Household spoons do not measure reliably. HSA’s cough-and-cold advice for children aged 2 to 12 specifies the supplied measure or one made for medicines. It also warns that the same brand can be sold in different strengths for adults and children. If the markings, concentration and directions do not agree, ask the pharmacist to check them before measuring anything. HSA
Why do modified-release and enteric coatings matter?
Crushing can destroy the release mechanism or expose a medicine to stomach acid. Modified-, sustained-, controlled- and extended-release forms release medicine differently from immediate-release products. ISMP explains that enteric coatings delay release until the small intestine. Removing the coating may let acid break down the medicine before absorption, or expose the stomach to irritation. Capsules containing sustained-release beads also lose their slow-release behaviour if the beads are crushed. ISMP
Crushing or chewing may release an extended-release medicine too quickly or destroy an enteric coating. In its April 2017 bulletin, ISMP describes a care-home resident whose K-TAB extended-release potassium chloride was crushed into applesauce. After 10 days she developed coffee-ground-like vomit and blood in her stools; hospital staff diagnosed gastrointestinal bleeding caused by the crushed tablets. The product was caustic when crushed. The NHS advises against crushing pills or opening capsules without professional advice. ISMP, NHS
MR, SR, CR, ER, XR, XL and EC can signal release or coating instructions. Some products have no obvious suffix. ISMP also describes an Asacol delayed-release mesalamine tablet split after its dashed design was mistaken for a score line. The insert said not to split or crush it; the error was found after a single split tablet and no harm occurred. Check the actual leaflet, not just the letters or markings. ISMP
HSA Appendix 7 distinguishes a line intended only to help swallowing from one that divides equal halves. The explanation belongs in the product description in the leaflet. It also calls for excipient details, including capsule-shell and film-coating ingredients, flavourings and colourants. HSA
What changes with creams, patches and inhalers?
The site, delivery system and technique change with each form. Topical products generally target a local site; a transdermal patch may deliver medicine through the skin over time. Similar-looking patches can have different wear periods, adhesion instructions, heat precautions and disposal requirements. Cutting a patch can alter delivery for some designs and should not be assumed acceptable.
Creams, ointments, lotions and gels can spread and absorb differently. The same percentage does not necessarily make two different forms directly substitutable, and “external use” directions matter around broken skin, eyes and mucous membranes.
Inhalers add a device to the formulation. A pressurised metered-dose inhaler, dry-powder inhaler and nebuliser solution can contain the same ingredient family but require different technique and strength interpretation. Products listed under salbutamol, budesonide or fluticasone should therefore be compared by device and presentation as well as ingredient. Poor technique can reduce delivery, so a device change deserves demonstration from a pharmacist or respiratory professional.
Eye drops, ear drops and nasal products make the route distinction especially visible: similar bottles do not make their contents interchangeable. Use only for the labelled site.
What changes the answer?
Swallowing, age, dexterity, vision, cognition, allergies, feeding tubes and the intended site and release pattern all matter. Kidney or liver function, pregnancy and other medicines can change suitability but are not solved by choosing a different physical form.
Children’s products and concentrated liquids require particular attention to the complete strength expression and measuring device. Inhalers require enough inspiratory ability and correct technique for that device. Patches require suitable skin and adherence to heat and placement instructions. Feeding-tube administration has product-specific compatibility issues and needs professional guidance.
Availability also does not establish equivalence. If a preferred form is unavailable, ask the prescriber or pharmacist to assess an authorised alternative rather than improvising with the form on hand.
What should you check before changing form?
Bring the pack or photos of every label panel, with the reason for considering a change. Check the ingredient, strength, form, route, release wording and directions. Mention swallowing problems, allergies, feeding tubes, pregnancy and difficulties using a measuring device, patch or inhaler.
Do not convert between tablet and liquid strengths, transfer medicine to an unlabelled container, or manipulate tablets and capsules unless the specific product has been checked. Seek urgent help for signs of a serious allergic reaction, such as swelling of the face or throat or difficulty breathing, regardless of dosage form.
Ingredient pages show presentations. The pharmacist checks whether a form fits the prescription and the person, using its leaflet for preparation and use.
Sources
- FDA: Dosage Forms.
- FDA: Generic Drugs.
- HSA Singapore: Guidance documents for therapeutic products, including Appendix 7 labelling guidance.
- Institute for Safe Medication Practices: Crushing or splitting the wrong tablet can be a deadly error.
- NHS: Problems swallowing pills.
- HSA Singapore: Cough and cold medicines for children.
